Literature DB >> 10617641

Secondary structure and structure-activity relationships of peptides corresponding to the subunit interface of herpes simplex virus DNA polymerase.

K G Bridges1, Q Hua, M R Brigham-Burke, J D Martin, P Hensley, C E Dahl, P Digard, M A Weiss, D M Coen.   

Abstract

The interaction of the catalytic subunit of herpes simplex virus DNA polymerase with the processivity subunit, UL42, is essential for viral replication and is thus a potential target for antiviral drug discovery. We have previously reported that a peptide analogous to the C-terminal 36 residues of the catalytic subunit, which are necessary and sufficient for its interaction with UL42, forms a monomeric structure with partial alpha-helical character. This peptide and one analogous to the C-terminal 18 residues specifically inhibit UL42-dependent long chain DNA synthesis. Using multidimensional (1)H nuclear magnetic resonance spectroscopy, we have found that the 36-residue peptide contains partially ordered N- and C-terminal alpha-helices separated by a less ordered region. A series of "alanine scan" peptides derived from the C-terminal 18 residues of the catalytic subunit were tested for their ability to inhibit long-chain DNA synthesis and by circular dichroism for secondary structure. The results identify structural aspects and specific side chains that appear to be crucial for interacting with UL42. These findings may aid in the rational design of new drugs for the treatment of herpesvirus infections.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10617641     DOI: 10.1074/jbc.275.1.472

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Identification of crucial hydrogen-bonding residues for the interaction of herpes simplex virus DNA polymerase subunits via peptide display, mutational, and calorimetric approaches.

Authors:  K G Bridges; C S Chow; D M Coen
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

2.  Evidence against a simple tethering model for enhancement of herpes simplex virus DNA polymerase processivity by accessory protein UL42.

Authors:  Murari Chaudhuri; Deborah S Parris
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

3.  Specific residues in the connector loop of the human cytomegalovirus DNA polymerase accessory protein UL44 are crucial for interaction with the UL54 catalytic subunit.

Authors:  Arianna Loregian; Brent A Appleton; James M Hogle; Donald M Coen
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

4.  Effects of substitutions of arginine residues on the basic surface of herpes simplex virus UL42 support a role for DNA binding in processive DNA synthesis.

Authors:  John C W Randell; Gloria Komazin; Changying Jiang; Charles B C Hwang; Donald M Coen
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

Review 5.  Replication and recombination of herpes simplex virus DNA.

Authors:  Isabella Muylaert; Ka-Wei Tang; Per Elias
Journal:  J Biol Chem       Date:  2011-03-01       Impact factor: 5.157

6.  Inhibition of human cytomegalovirus DNA polymerase by C-terminal peptides from the UL54 subunit.

Authors:  Arianna Loregian; Roberto Rigatti; Mary Murphy; Elisabetta Schievano; Giorgio Palu; Howard S Marsden
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

7.  Identification of conserved amino acids in the herpes simplex virus type 1 UL8 protein required for DNA synthesis and UL52 primase interaction in the virus replisome.

Authors:  Isabella Muylaert; Zhiyuan Zhao; Torbjörn Andersson; Per Elias
Journal:  J Biol Chem       Date:  2012-07-30       Impact factor: 5.157

8.  Enhanced delivery of exogenous peptides into the class I antigen processing and presentation pathway.

Authors:  Lolke De Haan; Arron R Hearn; A Jennifer Rivett; Timothy R Hirst
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

9.  Classification of human Herpesviridae proteins using Domain-architecture Aware Inference of Orthologs (DAIO).

Authors:  Christian M Zmasek; David M Knipe; Philip E Pellett; Richard H Scheuermann
Journal:  Virology       Date:  2019-01-06       Impact factor: 3.616

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.